Filing Alert: Molecular Templates Chapter 11

Molecular Templates, Inc. and its debtor affiliate⁽¹⁾, a Foxboro, MA-based clinical stage biopharmaceutical company, filed for Chapter 11 protection on Apr. 20 in the U.S. Bankruptcy Court for the District of Delaware.

The company reports $2.5 million in assets and $29.4 million in liabilities. The filing indicates that no funds will be available for distribution to unsecured creditors after administrative expenses are paid. The case number is 25-10739.

⁽¹⁾ Molecular Templates OpCo, Inc.

Top Unsecured Claims

Key Parties

Counsel:

• Eric D. Schwartz
• Morris, Nichols, Arsht & Tunnell LLP
• Email: eschwartz@morrisnichols.com

Signatories:

• Craig R. Jalbert – President and Chief Executive Officer

Equity Security Holders:

• Biotech Target N.V. – 19.4% Equity Interest
• Kevin Lalande – 10.1% Equity Interest
• Entities Affiliated with BVF Partners L.P. – 9.9% Equity Interest
• Entities Affiliated with SilverArc Capital Management, LLC – 9.9% Equity Interest
• Entities Affiliated with SHV Management Services, LLC – 9.9% Equity Interest
• K2 HealthVentures Equity Trust LLC – 9.9% Equity Interest
• Other Minority Holders – 30.9% Equity Interest

Bondoro Insights is continuing to monitor this case and will provide further coverage as appropriate.

Stay informed on every Chapter 11 bankruptcy case with liabilities exceeding $10 million. Subscribe for free to have our coverage delivered directly to your inbox, and explore our full archive of past summaries.

If you're already a subscriber and would like to receive timely filing alerts, please reach out and we'll add you to the distribution list.